Discovery of a New CDK4/6 and PI3K/AKT Multiple Kinase Inhibitor Aminoquinol for the Treatment of Hepatocellular Carcinoma

Zhong-Kun Xia(Zhengzhou University), Bing‐Hua Jiang(Utah Tech University)

Frontiers in Pharmacology

July 15, 2021

10.3389/fphar.2021.691769

Cited by 37

Related Papers

MiR-21 Induced Angiogenesis through AKT and ERK Activation and HIF-1α Expression

|PLoS ONE|2011|494

Analysis of MiR-195 and MiR-497 Expression, Regulation and Role in Breast Cancer

|Clinical Cancer Research|2011|338

Phosphoglycerate Kinase 1 Phosphorylates Beclin1 to Induce Autophagy

|Molecular Cell|2017|282

Cadmium Increases HIF-1 and VEGF Expression through ROS, ERK, and AKT Signaling Pathways and Induces Malignant Transformation of Human Bronchial Epithelial Cells

|Toxicological Sciences|2011|202

Vascular Endothelial Growth Factor Transcriptional Activation Is Mediated by Hypoxia-inducible Factor 1α, HDM2, and p70S6K1 in Response to Phosphatidylinositol 3-Kinase/AKT Signaling

|Journal of Biological Chemistry|2004|193